Carcinogenesis, Vol. 23, No. 3, 485-489,
March 2002
© 2002 Oxford University Press
CARCINOGENESIS |
Immunohistochemical detection of a substituted 1,N2-ethenodeoxyguanosine adduct by 
-6 polyunsaturated fatty acid hydroperoxides in the liver of rats fed a choline-deficient, L-amino acid-defined diet
Laboratory of Food and Biodynamics, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan,
1 School of Humanities for Environmental Policy and Technology, Himeji Institute of Technology, Himeji 670-0092, Japan and
2 Department of Oncological Pathology, Cancer Center, Nara Medical University, Nara, 634-8521, Japan
Endogenous lipid peroxidation products react with DNA and form exocyclic DNA adducts. The purpose of this study was to investigate the in vivo formation of 7-(2-oxo-heptyl)-substituted 1,N2-etheno-2'-deoxyguanosine adduct (Oxo-heptyl-
dG), one of the major products from the reaction of 13-hydroperoxyoctadecadienoic acid (13-HPODE) with dG. The monoclonal antibody specific to Oxo-heptyl-dG was prepared using a chemically synthesized conjugate of Oxo-heptyl-dG and carrier protein as immunogen. The characterization showed that the obtained antibody (mAb6A3) is specific to the Oxo-heptyl-dG moiety. Using the novel antibody, the presence of the Oxo-heptyl-dG adduct in vivo was immunohistochemically revealed in the liver of rats fed a choline-deficient, L-amino acid-defined diet, an endogenous carcinogenesis model, for 3 days. In addition, the Oxo-heptyl-dG formation was confirmed in DNAs treated with peroxidized linoleic acid, arachidonic acid and 
-linolenic acid, respectively, suggesting that the hydroperoxides of 
-6 polyunsaturated fatty acids could be the potential sources of Oxo-heptyl-dG formation in vivo. Collectively, the results in this study suggest the first evidence that the formation of Oxo-heptyl-dG, the -6 lipid hydroperoxide-mediated DNA adduct, may be a potential biomarker for the early phase of carcinogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Shibata, K. Iio, Y. Kawai, N. Shibata, M. Kawaguchi, S. Toi, M. Kobayashi, M. Kobayashi, K. Yamamoto, and K. Uchida Identification of a Lipid Peroxidation Product as a Potential Trigger of the p53 Pathway J. Biol. Chem., January 13, 2006; 281(2): 1196 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawai, H. Morinaga, H. Kondo, N. Miyoshi, Y. Nakamura, K. Uchida, and T. Osawa Endogenous Formation of Novel Halogenated 2'-Deoxycytidine: HYPOHALOUS ACID-MEDIATED DNA MODIFICATION AT THE SITE OF INFLAMMATION J. Biol. Chem., December 3, 2004; 279(49): 51241 - 51249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kawai, A. Furuhata, S. Toyokuni, Y. Aratani, and K. Uchida Formation of Acrolein-derived 2'-Deoxyadenosine Adduct in an Iron-induced Carcinogenesis Model J. Biol. Chem., December 12, 2003; 278(50): 50346 - 50354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Oe, J. S. Arora, S. H. Lee, and I. A. Blair A Novel Lipid Hydroperoxide-derived Cyclic Covalent Modification to Histone H4 J. Biol. Chem., October 24, 2003; 278(43): 42098 - 42105. [Abstract] [Full Text] [PDF]
|
|